Novavax, Inc. (NVAX)

131.69
NASDAQ
Prev Close 121.00
Day Low/High 118.31 / 136.36
52 Wk Low/High 37.37 / 331.68
Exchange NASDAQ
Shares Outstanding 74.09B
Market Cap 8.97B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Novavax Is Poised for Renewal After Its Correction

Novavax Is Poised for Renewal After Its Correction

Here's our updated analysis and trading strategy.

I'm Not Bailing on Johnson & Johnson Now

I'm Not Bailing on Johnson & Johnson Now

Don't forget, this is a very large company with a lot more than the vaccine going on.

The XBI SPDR S&P Biotech ETF Reaches a Critical Juncture

The XBI SPDR S&P Biotech ETF Reaches a Critical Juncture

XBI has shown a steep decline from the middle of February.

Deceptive Thursday, Rotational Roundabout, Biden Bits, Disparate Fed Data

Deceptive Thursday, Rotational Roundabout, Biden Bits, Disparate Fed Data

Plus, the efficacy rate of the still-pending Novavax Covid-19 vaccine against variants of the virus give reason for pause.

Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings

Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings

Among other things, the president works to align Democratic senators to support his massive Covid relief bill.

Unconvincing Rally, U.S. Dollar, Friday's 800-Pound Gorilla, Playing Pepper

Unconvincing Rally, U.S. Dollar, Friday's 800-Pound Gorilla, Playing Pepper

Everything came up roses Monday -- except for what matters most, broad participation.

What's Up at the Fed? Supply & Demand, 12 Trading Notes, Microsoft Conference

What's Up at the Fed? Supply & Demand, 12 Trading Notes, Microsoft Conference

Should we care about Australia's central bank taking overtly aggressive action to reign in the long end of their yield curve? Yes, we should.

This Is Why He Is The Smartest Trader in the World

* He shoots, he scores - with NVAX (+65% or +$87/share) today Several subscribers have expressed disinterest and even snarkiness in The Smartest Trader in the World's positions -- others like to see his book on almost a daily basis. I posted this up...

I've Come Around to Thinking of Boeing as an Investment

I've Come Around to Thinking of Boeing as an Investment

I think BA returns to normal as we do, as the airlines do... but with the defense contracting business as a foundation to rely upon.

Novavax Rated New Buy at Jefferies

The Meaning of Biden, Overbought Markets? Fun With Charts

The Meaning of Biden, Overbought Markets? Fun With Charts

Can corporate America grow sales for the fourth quarter? Then answer a question with a question.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Jim Cramer: The Seven Deadly Stock Sins (as Seen on Twitter)

Jim Cramer: The Seven Deadly Stock Sins (as Seen on Twitter)

Penny stocks are for suckers, and six other rules for better investing -- and tuning out the tweet noise.

Emergent BioSolutions Could See Further Upside Gains

Emergent BioSolutions Could See Further Upside Gains

Most of the indicators are still bullish in this name, although some profit-taking may be occurring.

Trade Cautiously With Sorrento Therapeutics

Trade Cautiously With Sorrento Therapeutics

Short-term traders may want to nail down profits and be careful in their trading strategy with this name.

Jim Cramer: What Happens in a Bull Market Is That Stocks Move Up on Nothing

Jim Cramer: What Happens in a Bull Market Is That Stocks Move Up on Nothing

Isaac Newton's first lesson: An object in motion stays in motion with the same speed and in the same direction unless acted upon by an unbalanced force.

The Relevance of the Russell 2000

The Relevance of the Russell 2000

The performance of IWM is telling you that all is not well in the overall U.S. economy.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Jim Cramer: How Do You Refute These Market Gains?

Jim Cramer: How Do You Refute These Market Gains?

This is pretty much exactly what you get when you have so much positive research.

These 3 Biotechs Have Decent Values

These 3 Biotechs Have Decent Values

One would need to use covered calls to initiate positions that provide a solid amount of downside protection.

Novavax and Its $1.6 Billion Award Just Got My Attention

Novavax and Its $1.6 Billion Award Just Got My Attention

The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.

Novavax Could Surprise on the Upside - No Bearish Divergences Yet

Novavax Could Surprise on the Upside - No Bearish Divergences Yet

Let's review the charts and indicators.

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.

China Headline Risk, Valuation Station and a Workday Play

China Headline Risk, Valuation Station and a Workday Play

WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.

Merck Is All In With a Threefold Approach to Covid-19

Merck Is All In With a Threefold Approach to Covid-19

I've been long Merck for a long time, since way before this pandemic became part of our lives.